Penumbra, Inc. (PEN)
NYSE: PEN · IEX Real-Time Price · USD
189.87
-0.94 (-0.49%)
At close: Jul 19, 2024, 4:00 PM
189.93
+0.06 (0.03%)
After-hours: Jul 20, 2024, 12:58 PM EDT
Penumbra Revenue
Penumbra had revenue of $1.10B in the twelve months ending March 31, 2024, with 23.87% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $278.66M with 15.43% year-over-year growth. In the year 2023, Penumbra had annual revenue of $1.06B with 24.95% growth.
Revenue (ttm)
$1.10B
Revenue Growth
+23.87%
P/S Ratio
6.72
Revenue / Employee
$260,900
Employees
4,200
Market Cap
7.36B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.06B | 211.39M | 24.95% |
Dec 31, 2022 | 847.13M | 99.54M | 13.32% |
Dec 31, 2021 | 747.59M | 187.18M | 33.40% |
Dec 31, 2020 | 560.41M | 13.01M | 2.38% |
Dec 31, 2019 | 547.41M | 102.47M | 23.03% |
Dec 31, 2018 | 444.94M | 111.17M | 33.31% |
Dec 31, 2017 | 333.76M | 70.45M | 26.75% |
Dec 31, 2016 | 263.32M | 77.22M | 41.50% |
Dec 31, 2015 | 186.10M | 60.59M | 48.27% |
Dec 31, 2014 | 125.51M | 36.66M | 41.26% |
Dec 31, 2013 | 88.85M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
The Ensign Group | 3.85B |
Jazz Pharmaceuticals | 3.84B |
Halozyme Therapeutics | 862.99M |
Ionis Pharmaceuticals | 776.62M |
Repligen | 607.45M |
Intra-Cellular Therapies | 513.93M |
Ascendis Pharma | 357.63M |
Blueprint Medicines | 282.21M |
PEN News
- 19 days ago - Penumbra, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024 - PRNewsWire
- 4 weeks ago - Top 3 Health Care Stocks That Could Blast Off In June - Benzinga
- 6 weeks ago - Penumbra, Inc. to Present at the Truist Securities MedTech Conference - PRNewsWire
- 2 months ago - Penumbra, Inc. to Present at the William Blair Growth Stock Conference - PRNewsWire
- 2 months ago - Penumbra, Inc. Reports First Quarter 2024 Financial Results - PRNewsWire
- 2 months ago - Penumbra, Inc. to Present at the RBC Capital Markets Global Healthcare Conference - PRNewsWire
- 3 months ago - Penumbra Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood Clots - PRNewsWire
- 3 months ago - Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024 - PRNewsWire